Clinical Trials List
Protocol NumberLOXO-IDH-20002
Active
2021-01-01 - 2026-12-31
Phase I
Recruiting2
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Nai-Jung Chiang Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- 劉奕廷 無
- Li-Tzong Chen Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Chien-Jui Huang Division of General Internal Medicine
- Kwang-Yu Chang Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- 顏志傑 無
- 姜乃榕 Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
180 participants
